The rewards of nicotine: Regulation by tissue plasminogen activator-plasmin system through protease activated receptor-1

Journal of Neuroscience

Volumn 26, Issue 47, 2006, Pages 12374-12383

  Nagai, Taku ^a,b   Ito, Mina ^a   Nakamichi, Noritaka ^a   Mizoguchi, Hiroyuki ^a   Kamei, Hiroyuki ^a   Fukakusa, Ayumi ^a   Nabeshima, Toshitaka ^b   Takuma, Kazuhiro ^a   Yamada, Kiyofumi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Behaviors; Dependence; Dopamine; Knock out mice; Nucleus accumbens; Protease

Indexed keywords

ACETYLCHOLINE; NICOTINE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEINASE ACTIVATED RECEPTOR 1; TISSUE PLASMINOGEN ACTIVATOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOPAMINE RELEASE; EXTRACELLULAR SPACE; GENE CONTROL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; MALE; MICRODIALYSIS; MICROINJECTION; MOUSE; NERVE ENDING; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION;

ACETYLCHOLINE; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CELLS, CULTURED; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EMBRYO; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, KNOCKOUT; NEURONS; NICOTINE; NICOTINIC AGONISTS; RADIOLIGAND ASSAY; RECEPTOR, PAR-1; REWARD; STATISTICS, NONPARAMETRIC; TISSUE PLASMINOGEN ACTIVATOR;

EID: 33751311987     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.3139-06.2006     Document Type: Article

References (48)

1. Baranes D, Lederfein D, Huang YY, Chen M, Bailey CH, Kandel ER (1998) Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21:813-825.
2. Berrendero F, Kieffer BL, Maldonado R (2002) Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in μ-opioid receptor knock-out mice. J Neurosci 22:10935-10940.
3. Calabresi P, Napolitano M, Centonze D, Marfia GA, Gubellini P, Teule MA, Berretta N, Bernardi G, Frati L, Tolu M, Gulino A (2000) Tissue plasminogen activator controls multiple forms of synaptic plasticity and memory. Eur J Neurosci 12:1002-1012.
4. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC (1994) Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368:419-424.
5. Center for Disease Control (2002) Cigarette smoking among adults in the United States, 2002. Morbid Mortal Weekely Rep 51:300-303.
6. Connolly AJ, Ishihara H, Kahn ML, Farese Jr RV, Coughlin SR (1996) Role of the thrombin receptor in development and evidence for a second receptor. Nature 381:516-519.
7. Corringer PJ, Le Novere N, Changeux JP (2000) Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol 40:431-458.
8. Costa M, Shen Y, Maurer F, Medcalf RL (1998) Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factor that recognise functional elements in the tissue-type plasminogen-activator gene promoter. Eur J Biochem 258:123-131.
9. Coughlin SR (2000) Thrombin signalling and protease-activated receptors. Nature 407:258-264.
10. Dani JA, De Biasi M (2001) Cellular mechanisms of nicotine addiction. Pharmacol Biochem Behav 70:439-446.
11. Dery O, Corvera CU, Steinhoff M, Bunnett NW (1998) Proteinase-activated receptors: novel mechanisms of signaling by serine proteases. Am J Physiol 274:C1429-C1452.
12. di Porzio U, Daguet MD, Glowinski J, Prochiantz A (1980) Effect of striatal cells on in vitro maturation of mesencephalic dopaminergic neurones grown in serum-free conditions. Nature 288:370-373.
13. Franklin JBJ, Paxinos GT (1997) The mouse brain in stereotaxic coordinates. New York: Academic.
14. Grand RJ, Turnell AS, Grabham PW (1996) Cellular consequences of thrombin-receptor activation. Biochem J 313:353-368.
15. Gualandris A, Jones TE, Strickland S, Tsirka SE (1996) Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 16:2220-2225.
16. Henningfield JE, Fant RV, Buchhalter AR, Stitzer ML (2005) Pharmacotherapy for nicotine dependence. CA Cancer J Clin 55:281-299.
17. Hung DT, Wong YH, Vu TK, Coughlin SR (1992) The cloned platelet thrombin receptor couples to at least two distinct effectors to stimulate phosphoinositide hydrolysis and inhibit adenylyl cyclase. J Biol Chem 267:20831-20834.
18. Jacovina AT, Zhong F, Khazanova E, Lev E, Deora AB, Hajjar KA (2001) Neuritogenesis and the nerve growth factor-induced differentiation of PC-12 cells requires annexin II-mediated plasmin generation. J Biol Chem 276:49350-49358.
19. Kuliopulos A, Covic L, Seeley SK, Sheridan PJ, Helin J, Costello CE (1999) Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy. Biochemistry 38:4572-4585.
20. Lee R, Kermani P, Teng KK, Hempstead BL (2001) Regulation of cell survival by secreted proneurotrophins. Science 294:1945-1948.
21. Lochner JE, Honigman LS, Grant WF, Gessford SK, Hansen AB, Silverman MA, Scalettar BA (2006) Activity-dependent release of tissue plasminogen activator from the dendritic spines of hippocampal neurons revealed by live-cell imaging. J Neurobiol 66:564-577.
22. Loew D, Perrault C, Morales M, Moog S, Ravanat C, Schuhler S, Arcone R, Pietropaolo C, Cazenave JP, van Dorsselaer A, Lanza F (2000) Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Biochemistry 39:10812-10822.
23. Mataga N, Mizuguchi Y, Hensch TK (2004) Experience-dependent pruning of dendritic spines in visual cortex by tissue plasminogen activator. Neuron 44:1031-1041.
24. McGehee DS, Role LW (1995) Physiological diversity of nicotinic acetylcholine receptors expressed by vertebrate neurons. Annu Rev Physiol 57:521-546.
25. Mifsud JC, Hernandez L, Hoebel BG (1989) Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis. Brain Res 478:365-367.
26. Nagai T, Yamada K, Yoshimura M, Ishikawa K, Miyamoto Y, Hashimoto K, Noda Y, Nitta A, Nabeshima T (2004) The tissue plasminogen activator-plasmin system participates in the rewarding effect of morphine by regulating dopamine release. Proc Natl Acad Sci USA 101:3650-3655.
27. Nagai T, Noda Y, Ishikawa K, Miyamoto Y, Yoshimura M, Ito M, Takayanagi M, Takuma K, Yamada K, Nabeshima T (2005a) The role of tissue plasminogen activator in methamphetamine-related reward and sensitization. J Neurochem 92:660-667.
28. Nagai T, Kamei H, Ito M, Hashimoto K, Takuma K, Nabeshima T, Yamada K (2005b) Modification by the tissue plasminogen activator-plasmin system of morphine-induced dopamine release and hyperlocomotion, but not anti-nociceptive effect in mice. J Neurochem 93:1272-1279.
29. Nakagami Y, Abe K, Nishiyama N, Matsuki N (2000) Laminin degradation by plasmin regulates long-term potentiation. J Neurosci 20:2003-2010.
30. Narita M, Usui A, Narita M, Niikura K, Nozaki H, Khotib J, Nagumo Y, Yajima Y, Suzuki T (2005) Protease-activated receptor-1 and platelet-derived growth factor in spinal cord neurons are implicated in neuropathic pain after nerve injury. J Neurosci 25:10000-10009.
31. Picciotto MR (2003) Nicotine as a modulator of behavior: beyond the inverted U. Trends Pharmacol Sci 24:493-499.
32. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996) Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382:255-257.
33. Riewald M, Kravchenko VV, Petrovan RJ, O'Brien PJ, Brass LF, Ulevitch RJ, Ruf W (2001) Gene induction by coagulation factor Xa is mediated by activation of protease-activated receptor 1. Blood 97:3109-3116.
34. Riewald M, Petrovan RJ, Donner A, Mueller BM, Ruf W (2002) Activation of endothelial cell protease activated receptor 1 by the protein C pathway. Science 296:1880-1882.
35. Sappino AP, Madani R, Huarte J, Belin D, Kiss JZ, Wohlwend A, Vassalli JD (1993) Extracellular proteolysis in the adult murine brain. J Clin Invest 92:679-685.
36. Scott ME, Dossani ZY, Sandkvist M (2001) Directed polar secretion of protease from single cells of Vibrio cholerae via the type II secretion pathway. Proc Natl Acad Sci USA 98:13978-13983.
37. Seeds NW, Basham ME, Haffke SP (1999) Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci USA 96:14118-14123.
38. Shiffman S, Ferguson SG, Gwaltney CJ, Balabanis MH, Shadel WG (2006) Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy. Psychopharmacology 184:637-644.
39. Shin CY, Kundel M, Wells DG (2004) Rapid, activity-induced increase in tissue plasminogen activator is mediated by metabotropic glutamate receptor-dependent mRNA translation. J Neurosci 24:9425-9433.
40. Siao CJ, Fernandez SR, Tsirka SE (2003) Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 23:3234-3242.
41. Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, Krug M, Reymann KG, Reiser G (2001) Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci 14:595-608.
42. Tran MH, Yamada K, Olariu A, Mizuno M, Ren XH, Nabeshima T (2001) Amyloid β-peptide induces nitric oxide production in rat hippocampus: association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 15:1407-1409.
43. Tsirka SE, Gualandris A, Amaral DG, Strickland S (1995) Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377:340-344.
44. Vu TK, Hung DT, Wheaton VI, Coughlin SR (1991) Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell 64:1057-1068.
45. Walters CL, Cleck JN, Kuo YC, Blendy JA (2005) μ-opioid receptor and CREB activation are required for nicotine reward. Neuron 46:933-943.
46. Weinstein JR, Gold SJ, Cunningham DD, Gall CM (1995) Cellular localization of thrombin receptor mRNA in rat brain: expression by mesencephalic dopaminergic neurons and codistribution with prothrombin mRNA. J Neurosci 15:2906-2919.
47. Yamada K, Nagai T, Nabeshima T (2005) Tissue plasminogen activator, synaptic plasticity and drug addiction. J Pharmacol Sci 97:157-161.
48. Zoli M, Moretti M, Zanardi A, McIntosh JM, Clementi F, Gotti C (2002) Identification of the nicotinic receptor subtypes expressed on dopaminergic terminals in the rat striatum. J Neurosci 22:8785-8789.